We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRSP
10926
CALL
BrightSpire Capital
BRSP
$633M
$143K ﹤0.01%
19,000
-59,700
-76% -$506K
FEDU
10927
Four Seasons Education Depositary Shares Rep 10 Ordinary Shares
FEDU
$20.9M
$143K ﹤0.01%
+13,131
New +$139K
MAPS
10928
PUT
DELISTED
WM TECHNOLOGY INC A
MAPS
$143K ﹤0.01%
43,500
-27,800
-39% -$156K
MLSS icon
10929
Milestone Scientific
MLSS
$43.9M
$143K ﹤0.01%
156,422
+143,473
+1,108% +$146K
OSUR icon
10930
PUT
OraSure Technologies
OSUR
$265M
$143K ﹤0.01%
52,700
+1,600
+3% +$7.96K
RGTI icon
10931
PUT
Rigetti Computing
RGTI
$6.28B
$143K ﹤0.01%
38,900
+5,600
+17% +$35.6K
XWEL icon
10932
PUT
XWELL
XWEL
$8.28M
$143K ﹤0.01%
10,370
+3,125
+43% +$54.9K
DMTK
10933
PUT
DELISTED
DermTech, Inc. Common Stock
DMTK
$143K ﹤0.01%
25,900
-25,900
-50% -$212K
SCRMW
10934
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$143K ﹤0.01%
375,002
-149,997
-29% -$73.6K
HEXO
10935
CALL
DELISTED
HEXO Corp. Common Shares
HEXO
$143K ﹤0.01%
48,605
-1,029
-2% -$4.91K
RKLY
10936
DELISTED
Rockley Photonics Holdings Limited
RKLY
$143K ﹤0.01%
+65,589
New +$201K
CRDF icon
10937
PUT
Cardiff Oncology
CRDF
$74.9M
$142K ﹤0.01%
64,600
-20,600
-24% -$34.5K
EYPT icon
10938
CALL
EyePoint Inc
EYPT
$1.27B
$142K ﹤0.01%
18,100
-12,900
-42% -$130K
KD icon
10939
Kyndryl
KD
$2.87B
$142K ﹤0.01%
14,497
-600,851
-98% -$6.99M
SACH
10940
CALL
Sachem Capital Corp
SACH
$37.9M
$142K ﹤0.01%
34,700
+24,700
+247% +$116K
TURN
10941
CALL
DELISTED
180 Degree Capital
TURN
$142K ﹤0.01%
23,300
-104,600
-82% -$667K
LYLT
10942
CALL
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$142K ﹤0.01%
39,900
+14,740
+59% +$158K
PAQCU
10943
DELISTED
Provident Acquisition Corp. Units
PAQCU
$142K ﹤0.01%
14,316
DADA
10944
CALL
DELISTED
Dada Nexus
DADA
$141K ﹤0.01%
17,400
-26,100
-60% -$201K
LFST icon
10945
CALL
Lifestance Health
LFST
$4.75B
$141K ﹤0.01%
25,400
-12,500
-33% -$95.7K
CYPH
10946
CALL
Cypherpunk Technologies Inc
CYPH
$69.4M
$141K ﹤0.01%
12,280
+3,780
+44% +$48.9K
PMCB icon
10947
PUT
PharmaCyte Biotech
PMCB
$5.92M
$141K ﹤0.01%
+62,600
New +$137K
PULM icon
10948
Pulmatrix
PULM
$5.62M
$141K ﹤0.01%
+30,628
New +$162K
SLNH icon
10949
Soluna Holdings
SLNH
$207M
$141K ﹤0.01%
1,389
+677
+95% +$132K
TXMD icon
10950
PUT
TherapeuticsMD
TXMD
$24M
$141K ﹤0.01%
14,200
+13,720
+2,858% +$131K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.